Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PriorixTetra and Meningitec co-administration in healthy children
NCT01506193Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of varicella virus vaccine live new seed process + measles, mumps, and rubella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started Feb 2012; status: completed.
02
Drugs
varicella virus vaccine live new seed process + measles, mumps, and rubella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT01506193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506193.